Published in Biotech Business Week, June 15th, 2006
"Despite significant advances in the diagnosis, staging and treatment of patients with renal cell carcinoma, recurrence rates following surgical resection of locally aggressive tumors remain high. In an effort to delay disease progression and improve survival, the concept of adjuvant therapy has been proposed," scientists writing in the journal Expert Opinion on Pharmacotherapy reported.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.